Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Lipids in Cardiovascular Disease

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1483778

Remnant cholesterol, not LDL cholesterol, is associated with the risk of hypertension in the middle-aged and elderly population: Bushehr Elderly Health (BEH) cohort

Provisionally accepted
  • 1Department of Basic Medical Sciences, Khoy University of Medical Sciences,, Khoy,, Iran
  • 2Department of Basic Medical Sciences, Torbat Jam Faculty of Medical Sciences,, Torbat Jam,, Iran
  • 3School of Nursing, Tehran University of Medical Sciences,, Tehran, Iran
  • 4Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences,, Tehran, Iran
  • 5Proteomics Research center, Shahid Beheshti University of Medical Sciences,, Tehran, Iran
  • 6Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences,, Tehran, Iran
  • 7The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences,, Bushehr, Iran
  • 8Department of Chemistry, Ghent University,, Ghent, Belgium
  • 9Metabolomics and Genomics Research Center, Institute of Endocrinology and Metabolism, Tehran University of Medical Sciences, Tehran, Alborz, Iran

The final, formatted version of the article will be published soon.

Background: Despite available studies, the link between dyslipidemia and hypertension remains unclear, particularly among different ethnicities, age groups, and genders. This study aimed to assess this association in the Iranian elderly population.In a cross-sectional study, we used data from phase II of the Bushehr Elderly Health Program (BEHP). Participants were divided into hypertensive and non-hypertensive groups based on their blood pressure. The association between lipid parameters and hypertension (HTN) was evaluated using multiple logistic regression analysis. Additionally, we conducted a subgroup analysis by gender, age, and BMI (Body Mass Index).Results: In this study, 1918 people with a mean age of 62.10±8.05 were included. Of them, 1133 (59.1%) were hypertensive, and 57.2% were females (1097). Among the lipid profiles, individuals with HTN had higher levels of triglyceride (TG) and remnant cholesterol (RC). There was a negative association between high-density lipoprotein (HDL-c) levels and high blood pressure 0.987(0.978-0.995), p:0.003, and a positive association between TG and RC≥30 levels and HTN ((1.003(1.002-1.005), p<0.001); (1.36 (1.123-1.648), p:0.002), respectively). This positive association was observed after full adjustment for age, gender, and BMI. While HDL-C was lower and RC levels were significantly higher only in the hypertensive people aged ≤65 (p<0.01), higher RC levels were observed in the hypertensive groups independent of BMI levels (p=0.004). Moreover, the levels of RC≥30 mg/dL were associated with the risk of HTN only in males.In the middle-aged and elderly hypertension population, there is a positive and statistically significant association between RC and HTN. This suggests that this indicator is associated with HTN, particularly in those with normal or subnormal levels of traditional risk factors. Moreover, this association may be affected by age and anthropometric parameters as well as life style factors.

Keywords: Hypertension, Remnant cholesterol, Elderly peoples, lipid profile, Dyslipidemia

Received: 28 Nov 2024; Accepted: 06 Aug 2025.

Copyright: © 2025 Esmaeili, Esmaeili, Fahimfar, Rezaei Tavirani, Razi, Nabipour, Khashayar and Bandarian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Fatemeh Bandarian, Metabolomics and Genomics Research Center, Institute of Endocrinology and Metabolism, Tehran University of Medical Sciences, Tehran, 1417863181, Alborz, Iran

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.